SaaS Metrics
Academic Publication Liquid Biopsy Based on Cell-Free DNA and RNA
Research Abstract & Technology Focus
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Liquid Biopsy Based on Cell-Free DNA and RNA
This review delves into the rapidly evolving landscape of liquid biopsy technologies based on cell-free DNA (cfDNA) and cell-free RNA (cfRNA) and their increasingly prominent role in precision medi...
Liquid biopsy in cancer: current status, challenges and future prospects
AbstractCancer has a high mortality rate across the globe, and tissue biopsy remains the gold standard for tumor diagnosis due to its high level of laboratory standardization, good consistency of r...
SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives
AbstractLiquid biopsy has emerged as a promising non-invasive strategy for cancer diagnosis, enabling the detection of various circulating biomarkers, including circulating tumor cells (CTCs), circ...
Analysis of cell-free DNA for cancer diagnostics using liquid biopsies
Chromatin organisation influences gene regulation and genome stability, yet its dysregulation in cancer remains incompletely understood. This has become particularly important for patient diagnosti...
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
No description provided.
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Liquid Biopsy Based on Cell-Free DNA and RNA'?
This literature focuses on: This review delves into the rapidly evolving landscape of liquid biopsy technologies based on cell-free DNA (cfDNA) and cell-free RNA (cfRNA) and their increasingly prominent role in precision medicine. With the advent of high-throughput DNA seque...
Which startups are commercializing the technology behind Liquid Biopsy Based on Cell-Free DNA and RNA?
Products like Fluido are bringing this to market. Their focus is: Turn any Figma shape into liquid metal in one click.
What other academic literature is closely related to 'Liquid Biopsy Based on Cell-Free DNA and RNA'?
Yes, highly correlated activity was mapped. An entry titled 'Liquid Biopsy Based on Cell-Free DNA and RNA' discusses this: This review delves into the rapidly evolving landscape of liquid biopsy technologies based on cell-free DNA (cfDNA) and cell-free RNA (cfRNA) and t...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
Product HuntFluido